Crispr Therapeutics shares tumble after significant earnings miss
In a challenging market environment, Steven Madden , Ltd. (NASDAQ:SHOO) stock has touched a 52-week low, dipping to $24.85. According to InvestingPro data, technical indicators suggest the stock is currently oversold, while the company maintains strong fundamentals with a healthy 3.23% dividend yield and 15.21% revenue growth. The fashion-forward footwear and accessories company has faced significant headwinds over the past year, with the stock price reflecting a substantial decline of 39.11% from the previous year. Investors are closely monitoring the company’s performance as it navigates through the pressures of changing consumer trends and the competitive retail landscape. The current price level presents a critical juncture for the company, with InvestingPro analysis indicating the stock is trading below its Fair Value, suggesting potential upside opportunity. Detailed insights and 12 additional ProTips are available through InvestingPro’s comprehensive research report.
In other recent news, Steven Madden reported its fourth-quarter 2024 earnings, surpassing analysts’ expectations with an earnings per share (EPS) of $0.55 and revenue of $582.3 million, both exceeding forecasts. The company demonstrated strong financial health for the full year, with revenue climbing 15.2% to $2.3 billion and net income rising to $192.4 million. Despite these positive results, concerns over future market conditions and guidance have been noted. The strategic acquisition of Kurt Geiger is expected to bolster Steven Madden’s revenue, contributing to a projected 17-19% increase for 2025. However, the company’s EPS forecast for FY25 fell short of consensus estimates, partly due to potential trade tariff impacts. Analysts from Jefferies and Telsey Advisory Group have both lowered their price targets for Steven Madden, citing concerns over gross margins and profitability. Both firms maintained their respective ratings, with Telsey setting a target of $38 and Jefferies at $36. Investors are closely monitoring the company’s strategic moves amid a challenging retail environment.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.